Antje Prasse

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 559 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +12

Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial

Jürgen Behr, Antje Prasse, Michael Kreuter et al. · The Lancet Respiratory Medicine · 2021 · 516 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +9

The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool.

Marc A. Judson, Ulrich Costabel, Marjolein Drent et al. · PubMed · 2014 · 504 citations

Veterinary Medicine, Pathology, Diagnostic Pathology +6

A Vicious Circle of Alveolar Macrophages and Fibroblasts Perpetuates Pulmonary Fibrosis via CCL18

Antje Prasse, Dmitri V. Pechkovsky, Galen B. Toews et al. · American Journal of Respiratory and Critical Care Medicine · 2006 · 503 citations

Veterinary Medicine, Immunology, Pathobiology +17

Inhibition of PDGF, VEGF and FGF signalling attenuates fibrosis

Nveed Chaudhary, Gerald J. Roth, Frank Hilberg et al. · European Respiratory Journal · 2007 · 393 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14